metabolic-diseases

Documents about metabolic-diseases

• Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis#883582ClinicalTrials.gov
• Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease#834399ClinicalTrials.gov
• Atypical diabetes subtypes in Black African populations#130658Springer Nature OA
• Cardiovascular Disease Risk Factors in Chinese American Immigrants#245386ClinicalTrials.gov
• Implementing Digital Health in a Learning Health System#303623ClinicalTrials.gov
• Metabolic vulnerability, genetic susceptibility, and incident age-related eye diseases: a prospective cohort study.#368155NCBI PubMed Central
• Psychosocial stress-associated alterations in microRNAs and their relevance for metabolic diseases: A systematic review.#440613NCBI PubMed Central
• Immune and metabolic signatures characterise constipation-driven endophenotypes in Parkinson’s disease#446892ResearchOnline@ND
• Treatment of Overweight in General Practice#803152ClinicalTrials.gov
• GH and Cardiovascular Risk Factors#864197ClinicalTrials.gov
• A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)#908572ClinicalTrials.gov
• Clustering patterns of behavioral and metabolic risk factors for noncommunicable diseases in Iran: findings from a national STEPS survey#669671Europe PMC
• Beneficial Effects of Dietary and Lifestyle Change in Overweight and Obese Subjects#848602ClinicalTrials.gov
• Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)#858359ClinicalTrials.gov
• Single-Dose And Multiple-Dose Safety And Tolerability Study Of PF-04856883 In Type 2 Diabetic Adult Females#321667ClinicalTrials.gov
• Long-term Effect of Steroid on Metabolic Diseases in Asthmatics#18744ClinicalTrials.gov
• Building a credibility-based framework for target discovery: Perspectives from tRNA synthetase-linked metabolic diseases.#143145NCBI PubMed Central
• The gut microbiome-bile acid-FXR interplay: a pivotal axis in metabolic and gastrointestinal diseases.#154269NCBI PubMed Central
• Epidemiological and clinical data from the European Lipodystrophy Registry#194454HAL (France)
• Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate#314270ClinicalTrials.gov
• Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate#369975ClinicalTrials.gov
• SARS-CoV-2 and diabetes: a post-pandemic reappraisal#416623Springer Nature OA
• The impacts of caring for children with inherited metabolic diseases for families: a cross-sectional study.#472536NCBI PubMed Central
• Meta-analysis of Low-calorie Sweetened Beverages and Cardiometabolic Outcomes#683041ClinicalTrials.gov
• Effects of Gender-Affirming Hormone Therapy Among Transgender Women#856984ClinicalTrials.gov
• Use of the DBS for the Follow-up of Blood Clinical Parameters of Old People#866410ClinicalTrials.gov
• Lipoprotein and Apolipoproteins With Metabolic Liver Diseases#873696ClinicalTrials.gov
• Mitochondrial Stress, Brain Imaging, and Epigenetics#911289ClinicalTrials.gov
• 100-Year Human Aging Study#871146ClinicalTrials.gov
• Burden of metabolic dysfunction-associated steatotic liver disease in the Asia-Pacific region from 1990 to 2023#305634Recep Tayyip Erdoğan University Institutional Repository
• Metabolic and vascular outcomes after transition to the MiniMed 780G system in adults ≥65 years with type 1 diabetes: a randomised, single-centre study#416637Springer Nature OA
• Identification and Characterization of NAFLD in Turkey#287436ClinicalTrials.gov
• AI in variant analysis: fast track to genetic diagnoses#316797Springer Nature OA
• STREAMLINING THE DEVELOPMENT OF THERAPEUTIC GENOME EDITING FOR METABOLIC DISEASES#929276ScholarlyCommons
• CKM Syndrome Prevalence and Its Association With SCORE-2 and BRI#993008ClinicalTrials.gov
• A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II#844256ClinicalTrials.gov
• Metabolic risk and metabolic dysfunction–associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study#355242PLOS
• Investigating Myosteatosis in Steatotic Liver Diseases#862267ClinicalTrials.gov
• <b>Poster presented at EASL 2026: </b>Metabolic matters: real-world assessment of metabolic dysfunction–associated steatotic liver diseases in the United States by integrating international classification of diseases codes and non-invasive tests for improved detection#226644Figshare
• National Institute for Health and Care Research Global Health Research Centre for Multiple Long-Term Conditions#463626ClinicalTrials.gov
• Adrenaline is a prominent driver of inflammatory responses following hypoglycaemia#130662Springer Nature OA
• Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients#141196ClinicalTrials.gov
• Psychosocial, Environmental, and Chronic Disease Trends in Puerto Rico#162338ClinicalTrials.gov
• Pathophysiology and Management of Fatigue in Neuromuscular Diseases#330438IRIS
• Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients#843127ClinicalTrials.gov
• Vitamin D and Health Outcomes in Preterm Born Population#807203ClinicalTrials.gov
• A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus#982016ClinicalTrials.gov
• Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause#847216ClinicalTrials.gov
• Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis#901335ClinicalTrials.gov
• Assessing Feasibility of a Digital Health Intervention for Multiple Long-Term Condition Care in Primary Health Settings in India and Nepal#426677ClinicalTrials.gov